Skip to content
Menu
  • Blog
  • Dividend Stock Info Cards
  • YouTube Channel
  • Favorite Books
  • Videos and Podcasts
  • Resources
  • Portfolio
  • About
Menu

Dividend Kings Overview & Valuation Series – Kimberly-Clark Corporation (KMB)

Posted on September 15, 2022September 15, 2022 by Jeremy Shirey

Welcome to this series where I will be reviewing all the Dividend Kings and providing an overview and valuation calculation on the companies. Dividend Kings are a rare breed of Dividend Growth Companies. These companies have managed to raise their dividend for 50 or more years consecutively. Through all types of market swings, economic trouble, wars, recessions, these companies have seen it all and continue to reward shareholders with rising dividend income.

This week’s entry will focus on:

KMB – Kimberly-Clark Corporation

—-

Overview

Kimberly-Clark Corporation manufactures and markets personal care and consumer tissue products worldwide. 

It operates through three segments: 

  • Personal Care – brands include Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and others 
  • Consumer Tissue – brands include Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and others
  • K-C Professional – brands include Kleenex, Scott, WypAll, Kimtech, and KleenGuard

Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

(Source: Company Website)

—-

Metrics:

Dividend Amount: $4.64

Dividend Yield: 3.81%

5 Year Dividend CAGR: 3.82%

Payout Schedule: January, April, July, October

Dividend Payout Ratio: 87.88%

Years of Dividend Increases: 50 Years

P/E: 18.50

Analyst 5 Year Earnings Growth Estimate: 5.99%

—-

Valuation:

Current Price: $121.88 (9/15/22)

DCF (10% RRR): $95.64

P/E Mean Reversion: $115.16

Dividend Yield Theory: $141.46

Average of the three: $117.42

Analyst 1 year Price Target: $133.12

—-

Commentary:

Kimberly-Clark is a global manufacturer and distributor of consumer personal care and tissue products.  You may not be familiar with the company name, but I am certain you have at least a few of their products in your home.  The company has been in business for 150 years and per their website sells brands in more than 175 countries around the world.  In fact, they state that a fourth of the global population uses their products each day.

KMB has raised its dividend for 50 years, which makes them one of the newest Dividend Kings.  This is a very consistent company with brands that are consumed and replaced regularly.  The current yield at 3.81% is solid but their 5 year dividend CAGR is only 3.82%, which is a little on the low end but a solid combination for such a reliable name.  This dividend CAGR is in line with the company’s projected earnings growth. The payout ratio is currently high but the company is forecasted to grow earnings over the next year and a half, which will reduce the payout ratio.

The company’s revenue has been up over the past 5 years with total revenue rising from $18.5B in 2018 to $20.1B today, with a major increase starting in 2021, most likely due to the pandemic related rebound, but net income has not been as consistent, with the bottom line variable throughout that time. The stock has increased only 0.78% over the past 5 years, compared to the S&P’s return of 56.89%.  Over the past year the stock is down 10.90% compared to the S&P being down 12.48%. 

The company is facing headwinds on the cost of goods sold as inflation and supply chain disruptions have caused the input pricing to go up more than the company can raise prices. 

KMB has provided a consistent and stable dividend, but the company has struggled both in company growth and share price appreciation over the past five years.  Their products are universally used but the industry has very little organic growth, and will probably only grow the same as GDP and population growth. While I own the company I am not adding additional shares and have turned off the dividend reinvestment to allocate those funds to better opportunities.  The current dividend growth and capital appreciation is not currently attractive to me as an investment.  That said, the consistency and length of dividend payments shows that this may be a good option for your portfolio if you feel like the company can continue to grow their business.

Disclosure:  I own shares of KMB.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Click here to cancel reply.

Please Login to Comment.

Sign up to receive notifications of new posts!

Check your inbox or spam folder to confirm your subscription.

  • @JerShir
  • August 2025
  • June 2025
  • April 2025
  • January 2025
  • November 2024
  • September 2024
  • January 2024
  • October 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • Article Topic

    • Blog 101
    • Book Review 5
    • Company Analysis 37
    • Dividend Kings Series 16
    • Education 12
    • Market Commentary & Valuations 24
    • Sunday Afternoon Musings on DGI Series 8
    • Uncategorized 3
    • Valuation 1

© 2026 | Powered by Superbs Personal Blog theme